We are the European Breast Cancer Coalition, with 47 EU and Extra-EU member countries
Europa Donna is an independent non-profit organisation whose members are affiliated groups from countries throughout Europe.
The Coalition works to raise awareness of breast cancer and to mobilise the support of European women in pressing for improved breast cancer education, appropriate screening, optimal treatment and increased funding for research.
Europa Donna represents the interests of European women regarding breast cancer to local and national authorities as well as to institutions of the European Union.
Public Affairs and Advocacy
After decades of dedication, Europa Donna has secured a place at the table for European Parliament activities and works hand-in-hand with Members of the European Parliament (MEPs).
In time, this direct involvement has extended to the European Commission, which led to EUROPA DONNA actively cooperating in developing and regularly updating the ECIBC Guidelines and Quality Assurance Scheme.
In addition to this direct collaboration, Europa Donna partners with European-level organisations and initiatives which aim at maintaining breast cancer issues high on the agenda and duly addressed by all EU institutions.
News & Events
Discover New Content on EmpowerED
Have you explored EmpowerED, Europa Donna’s Breast Cancer Advocacy Academy? The platform offers trusted, evidence-based information to help advocates and anyone interested in breast cancer strengthen their knowledge and learn at their own pace. Newly added content includes presentations from the 17th Europa Donna Pan-European Conference and the 15th European Breast Cancer Conference. Among the…
read more
Susanne Dieroff Hay Calls for PROMs to Become a Core Part of Cancer Care
On 13 July 2026, Europa Donna Board Member and President of Bröstcancerförbundet Susanne Dieroff Hay brought a powerful patient perspective to the European Cancer Organisation’s Community 365 Roundtable on patient-reported outcome measures (PROMs). The event gathered more than 150 participants to discuss their use in clinical care, research, regulation and policy. Susanne stressed that, as…
read more
